MCL

Hot Off The Wires

Oncternal Therapeutics Presents New Preclinical Data from its anti-ROR1 Cell Therapy … 6/10/2022

Oncternal Therapeutics Presents Rationale and Plans for its Registrational Phase 3 Study … 6/10/2022

Cogent Biosciences Announces Positive Initial Clinical Data from Ongoing Phase 2 APEX … 6/10/2022

Oncternal Therapeutics to Participate in the Jefferies Healthcare Conference 2022 6/2/2022

Oncternal Therapeutics Reports Granting of Inducement Award Under Nasdaq Listing Rule 5635(… 6/1/2022

NovalGen announces compelling data from the Phase 1/2 Study of NVG-… 5/26/2022

Oncternal Therapeutics Presents Updated Interim Data for Zilovertamab in Combination with Ibrutinib … 5/26/2022

CRISPR Therapeutics Announces the Appointment of Phuong Khanh Morrow, M.D., FACP, … 5/16/2022

Vincerx Pharma Reports First Quarter 2022 Financial Results and Provides a Corporate … 5/12/2022

Nkarta Reports First Quarter 2022 Financial Results and Corporate Highlights 5/12/2022

Oncternal Therapeutics Provides Business Update and Announces First Quarter 2022 Financial Results 5/5/2022

Oncternal Therapeutics Reports Granting of Inducement Award Under Nasdaq Listing Rule 5635(… 5/2/2022

Luxeptinib Preclinical Data Extend Potential Applications from Oncology to Inflammation 5/2/2022

Oncternal Therapeutics to Provide Business Update and Report First Quarter 2022 Financial … 4/28/2022

Nkarta Announces Positive Preliminary Dose Finding Data for Two Lead Engineered Natural … 4/25/2022

more news »

Quicklinks